These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2516014)

  • 1. A cost-effectiveness analysis of a simple micromethod for hepatitis B screening in hepatitis B virus control programmes.
    Lansang MA; Domingo E; Lingao A; West S
    Int J Epidemiol; 1989; 18(4 Suppl 2):S38-43. PubMed ID: 2516014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of prenatal screening and immunization for hepatitis B virus.
    Arevalo JA; Washington AE
    JAMA; 1988 Jan; 259(3):365-9. PubMed ID: 2961895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of hepatitis B infection in newborns through mass screening and delayed vaccination of all infants of mothers with hepatitis B surface antigen.
    Schalm SW; Mazel JA; de Gast GC; Heijtink RA; Botman MJ; Bänffer JR; Cerards LJ; Zwijnenberg J; Fetter WP; Nuijten SM
    Pediatrics; 1989 Jun; 83(6):1041-8. PubMed ID: 2726331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Necessity for routine obstetric screening for hepatitis B surface antigen.
    Greenspoon JS; Martin J; Greenspoon RL; McNamara BT
    J Reprod Med; 1989 Sep; 34(9):655-8. PubMed ID: 2530344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results and experiences of HBsAG determination with passive hemagglutination (Serotest SSW/HBsAG)].
    Steinwehr D; Jülich WD; Kober P
    Z Arztl Fortbild (Jena); 1988; 82(9):409-12. PubMed ID: 3218267
    [No Abstract]   [Full Text] [Related]  

  • 6. Failure of immune serum globulin to prevent hepatitis B virus infection in infants born to HBsAg-positive mothers.
    Tong MJ; McPeak CM; Thursby MW; Schweitzer IL; Henneman CE; Ledger WJ
    Gastroenterology; 1979 Mar; 76(3):535-9. PubMed ID: 85562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B surface antigen screening in a nonindigent population.
    Meyer MC; Mead PB; Capeless EL
    J Reprod Med; 1992 Dec; 37(12):953-5. PubMed ID: 1287203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The need and value of routine screening of all pregnant women for hepatitis B surface antigen.
    Capar M; Kosić-Andrasević V; Popić G; Raguz L; Mahuĺja-Stamenković V; Zuzek A; Dujmović A; Milevoj-Razem M; Ljutić S
    Acta Med Croatica; 1995; 49(4-5):161-4. PubMed ID: 8630446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An economic analysis of premarriage prevention of hepatitis B transmission in Iran.
    Adibi P; Rezailashkajani M; Roshandel D; Behrouz N; Ansari S; Somi MH; Shahraz S; Zali MR
    BMC Infect Dis; 2004 Sep; 4():31. PubMed ID: 15347430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between the HBsAg-positive infection status of mothers and the non/low-response to hepatitis B vaccine of their infants].
    Yang ZQ; Hao HY; Shi XH; Fu ZD; Zhang F; Wang XF; Xu XX; Wang B; Wen HX; Feng SY; Wang B; Wang SP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):805-809. PubMed ID: 29936751
    [No Abstract]   [Full Text] [Related]  

  • 11. KEMRI Hep-cell II hepatitis B surface antigen screening kit.
    Okoth FA; Kaiguri PM; Mathenge E; Tuei J; Muchiri S; Owino N; Kamau G; Kulundu J; Njuguna A; Tukei PM; Yano M; Naruse T
    East Afr Med J; 1999 Sep; 76(9):530-2. PubMed ID: 10685326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP
    Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers.
    Chen DS; Hsu NH; Sung JL; Hsu TC; Hsu ST; Kuo YT; Lo KJ; Shih YT
    JAMA; 1987 May; 257(19):2597-603. PubMed ID: 3573257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan.
    Lo KJ; Tsai YT; Lee SD; Yeh CL; Wang JY; Chiang BN; Wu TC; Yeh PS; Goudeau A; Coursaget P
    Hepatogastroenterology; 1985 Apr; 32(2):65-8. PubMed ID: 3159639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of hepatitis B immune globulin in prevention of perinatal transmission of the hepatitis B virus.
    Nair PV; Weissman JY; Tong MJ; Thursby MW; Paul RH; Henneman CE
    Gastroenterology; 1984 Aug; 87(2):293-8. PubMed ID: 6376265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Success of a program of routine prenatal screening for hepatitis B surface antigen: the first 2 years.
    Okun NB; Larke RP; Waters JR; Joffres MR
    CMAJ; 1990 Dec; 143(12):1317-21. PubMed ID: 2147576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis.
    Krahn M; Detsky AS
    Med Decis Making; 1993; 13(1):4-20. PubMed ID: 8433635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HBsAg carriers in Bratislava and its surroundings and detection by reverse passive haemagglutination (author's transl)].
    Nováková J; Hrubisko M; Pokorná G
    Cas Lek Cesk; 1980 Sep; 119(36-37):973-5. PubMed ID: 7438170
    [No Abstract]   [Full Text] [Related]  

  • 19. Significance of detecting anti-HBc among Egyptian male blood donors negative for HBsAg.
    Antar W; El-Shokry MH; Abd El Hamid WA; Helmy MF
    Transfus Med; 2010 Dec; 20(6):409-13. PubMed ID: 20573069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five years of vaccination campaign against hepatitis B in Italy in infants of hepatitis B surface antigen carrier mothers.
    Stroffolini T; Pasquini P
    Ital J Gastroenterol; 1990 Aug; 22(4):195-7. PubMed ID: 2131945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.